Sinphar Pharmaceutical Co Ltd (1734) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sinphar Pharmaceutical Co Ltd (1734) has a cash flow conversion efficiency ratio of 0.031x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$116.42 Million ≈ $3.67 Million USD) by net assets (NT$3.81 Billion ≈ $119.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 1734 market cap for the company's overall valuation and market capitalisation.
Sinphar Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Sinphar Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sinphar Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sinphar Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Sinphar Pharmaceutical Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Allpark Empreendimentos Participações e Serviços S.A
SA:ALPK3
|
1.176x |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA
|
0.056x |
|
AK Sigorta AS
IS:AKGRT
|
0.178x |
|
Columbus A/S
CO:COLUM
|
0.010x |
|
SWK Holdings Corp
NASDAQ:SWKH
|
0.004x |
|
Ramada Investimentos e Industria S.A
LS:RAM
|
0.094x |
|
Tornado Global Hydrovacs Ltd
V:TGH
|
0.209x |
|
Smec Co.Ltd
KQ:099440
|
0.089x |
Annual Cash Flow Conversion Efficiency for Sinphar Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Sinphar Pharmaceutical Co Ltd from 2003 to 2025. View Sinphar Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$3.72 Billion ≈ $117.05 Million |
NT$584.66 Million ≈ $18.42 Million |
0.157x | -5.97% |
| 2024-12-31 | NT$3.55 Billion ≈ $111.72 Million |
NT$593.51 Million ≈ $18.70 Million |
0.167x | +91.89% |
| 2023-12-31 | NT$3.40 Billion ≈ $107.05 Million |
NT$296.37 Million ≈ $9.34 Million |
0.087x | -34.03% |
| 2022-12-31 | NT$3.22 Billion ≈ $101.35 Million |
NT$425.30 Million ≈ $13.40 Million |
0.132x | +200.15% |
| 2021-12-31 | NT$3.08 Billion ≈ $96.95 Million |
NT$135.54 Million ≈ $4.27 Million |
0.044x | -5.41% |
| 2020-12-31 | NT$3.14 Billion ≈ $99.05 Million |
NT$146.39 Million ≈ $4.61 Million |
0.047x | +287.63% |
| 2019-12-31 | NT$3.20 Billion ≈ $100.91 Million |
NT$-79.49 Million ≈ $-2.50 Million |
-0.025x | -206.85% |
| 2018-12-31 | NT$3.42 Billion ≈ $107.84 Million |
NT$79.50 Million ≈ $2.50 Million |
0.023x | -61.69% |
| 2017-12-31 | NT$3.63 Billion ≈ $114.26 Million |
NT$219.87 Million ≈ $6.93 Million |
0.061x | +162.99% |
| 2016-12-31 | NT$3.78 Billion ≈ $119.16 Million |
NT$87.18 Million ≈ $2.75 Million |
0.023x | -67.46% |
| 2015-12-31 | NT$3.96 Billion ≈ $124.77 Million |
NT$280.53 Million ≈ $8.84 Million |
0.071x | +94.44% |
| 2014-12-31 | NT$4.08 Billion ≈ $128.50 Million |
NT$148.58 Million ≈ $4.68 Million |
0.036x | -57.16% |
| 2013-12-31 | NT$3.49 Billion ≈ $110.08 Million |
NT$297.09 Million ≈ $9.36 Million |
0.085x | +39.12% |
| 2012-12-31 | NT$2.69 Billion ≈ $84.77 Million |
NT$164.45 Million ≈ $5.18 Million |
0.061x | -27.91% |
| 2011-12-31 | NT$2.66 Billion ≈ $83.82 Million |
NT$225.58 Million ≈ $7.11 Million |
0.085x | -29.94% |
| 2010-12-31 | NT$2.16 Billion ≈ $68.08 Million |
NT$261.49 Million ≈ $8.24 Million |
0.121x | -18.26% |
| 2009-12-31 | NT$2.09 Billion ≈ $65.96 Million |
NT$309.94 Million ≈ $9.76 Million |
0.148x | -3.04% |
| 2008-12-31 | NT$1.77 Billion ≈ $55.92 Million |
NT$271.01 Million ≈ $8.54 Million |
0.153x | +48.45% |
| 2007-12-31 | NT$1.70 Billion ≈ $53.56 Million |
NT$174.85 Million ≈ $5.51 Million |
0.103x | +2.74% |
| 2006-12-31 | NT$1.66 Billion ≈ $52.42 Million |
NT$166.57 Million ≈ $5.25 Million |
0.100x | +34.84% |
| 2005-12-31 | NT$1.64 Billion ≈ $51.81 Million |
NT$122.09 Million ≈ $3.85 Million |
0.074x | -44.09% |
| 2004-12-31 | NT$1.32 Billion ≈ $41.47 Million |
NT$174.81 Million ≈ $5.51 Million |
0.133x | +3.62% |
| 2003-12-31 | NT$942.90 Million ≈ $29.71 Million |
NT$120.84 Million ≈ $3.81 Million |
0.128x | -- |
About Sinphar Pharmaceutical Co Ltd
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, in… Read more